David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments. David Mitchell, PharmD ...
In 2010, halfway through his medical training at the University of Pennsylvania, David Fajgenbaum, MD, MBA, lay in a bed at Duke University Hospital, dying from a rare disease. Tests showed he had ...
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for ...
Discover expert insights, market forecasts, and best practices in our latest issue, crafted to empower financial advisors for success in the year ahead and beyond.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results